- T22 -

Advancing Innovation in Multiple Myeloma Research Together with gifted researchers from around the world we envision a strong collaboration sparking new discoveries and hope. Who We Are The founder of Scottrade grew that company from a single office to a 4 billion business before selling it to TD Ameritrade two years after he was diagnosed with multiple myeloma. His next step was clear. He and wife Paula would establish the Paula and Rodger Riney Foundation with proceeds from the companys sale to fund scientific research leading to a better understanding and possible cure of multiple myeloma and related cancers.